Work

Effects of empagliflozin in patients at risk of heart failure: the empire prevent metabolic trial

Year: 2026

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: European Journal of Preventive Cardiology

DOI: 10.1093/eurjpc/zwag010

Authors: Camilla Fuchs Andersen, Julie Hempel Larsen, Massar Omar, Nina Nouhravesh, Caroline Michaela Kistorp, Christian Tuxen, Filip K Knop, Per Lav Madsen, Julie Lyng Forman, Filip Søskov Davidovski, Lars Køber, Morten Schou, Jacob Eifer Møller, Jesper Jensen

Institutions: University of Copenhagen, Herlev Hospital, Copenhagen University Hospital, Gentofte Hospital, University of Southern Denmark, Odense University Hospital, Rigshospitalet, Bispebjerg Hospital, Novo Nordisk (Denmark)

Language: English

Topic: Heart Failure Treatment and Management

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Hjerteforeningen, Arvid Nilssons Fond, Aase og Ejnar Danielsens Fond, Odense Universitetshospital, Eva og Henry Frænkels Mindefond, KV Fonden

Awards: G3397980767, G606500090

OpenAlex ID: W7120176920

FWCI: 9.575

Cites: 32

Cited by: 2

Related to: